Chemical.AI and Chemaxon announce collaboration in the integration of scientific information software.

パトコア株式会社

Chemical.AI, a global leader in artificial intelligence (AI) for synthetic route design and prediction, and Chemaxon, a leading company in chemical and biological software development, have announced a strategic partnership that will allow access to Chemical.AI's reverse synthesis tool, ChemAIRS, as an option from Chemaxon's drug discovery platform, Design Hub. This collaboration creates compatibility between Chemical.AI's ChemAIRS and Chemaxon's Design Hub, enabling a seamless user workflow and one-stop service that integrates compound design tracking and prioritization features from Design Hub with the innovative synthetic routes generated in minutes using ChemAIRS's diverse strategies. For more details, please visit our website.

Date and time
Capital
Entry fee

Related product information

Innovative drug discovery information platform 'Design Hub'
Design HUB is a groundbreaking information platform that integrates hypothesis-driven and data-driven approaches to streamline the DMTA cycle in drug discovery.

【Other Features】 <Integration of External Resources> ■ Customizable plugins based on JavaScript and a wealth of templates ■ Data integration with any service via REST, SQL, or CLI methods <Management of Ideas and Projects> ■ Organize and manage original data and discussion content by hypothesis ■ Save data used for analysis during the structural optimization phase as a design set ■ Visualize who is responsible for what and the progress status using a Kanban board *For more details, please refer to the PDF document or feel free to contact us.

Related catalog

Compound design platform "Design Hub" collaboration foundation

PRODUCT

Contact this catalog

Return to news list

パトコア株式会社 Official site